A new UN Sustainable Energy for All initiative was announced this week with the goal of “doubling the global use of renewable energy and ensuring universal energy access by 2030.”
Co-chaired by the UN Food and Agricultural Organization (FAO) and the Roundtable on Sustainable Biomaterials, the initiative includes Novozymes, a global technology provider for the biofuels industry, as a partner in the project to scale up the development and deployment of sustainable bioenergy solutions.
“With this initiative, we help bring together a diverse range of global frontrunners to advance the development and use of sustainable bioenergy in countries where the environmental and socio-economic benefits are greatest,” said Thomas Videbæk, Executive Vice President for Business Development with Novozymes. “It is a unique chance to involve governments, industry, financial institutions, academia, and civil society to identify opportunities where action on sustainable bioenergy can be accelerated.”
Accounting for nearly half of the global enzyme market, Novozymes has been a major player in the commercial development of cellulosic ethanol. “We produce the enzymes that help break down starch and make sugar available for first generation ethanol and we are working on a number of projects to help breakdown cellulosic material,” said Videbæk in an interview today with DomesticFuel.
Videbæk says next generation biofuels are considered “sustainable bioenergy” under the initiative’s High Impact Opportunity (HIO) goals. “I look at the biofuel area, be it first or second generation, as very sustainable forms of energy,” said Videbæk. “We certainly hope to see that continues going forward.”
Which is one of the reasons Novozymes wanted to be part of this initiative that they hope will help get some regulatory clarity regarding sustainable bioenergy around the world, including the United States. “And we can get politicians to commit to mandates and targets for this type of energy, because we believe that is for the best of the planet’s future,” Videbæk said.
In this interview, Videbæk explains much more about the new initiative and Novozymes’ role in it. Interview with Thomas Videbæk, Novozymes